AMPH - Amphastar Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Rancho Cucamonga,
United States
Type: Equity
AMPH price evolution
AMPH
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $189.85 | $201.38 | $144.53 | |
| Short term investments | $30.36 | $90.61 | $114.71 | |
| Net receivables | $144.98 | $131.41 | $138.11 | $114.94 |
| Inventory | $130.32 | $122.41 | $115.49 | $105.83 |
| Total current assets | $545.95 | $482.64 | $555.08 | $489.6 |
| Long term investments | $9.94 | $15.16 | $15.21 | |
| Property, plant & equipment | $327.52 | $320.57 | $320.39 | $315.64 |
| Goodwill & intangible assets | $600.85 | $607.06 | $613.29 | |
| Total noncurrent assets | $1008.88 | $1019.24 | $1023.31 | |
| Total investments | $40.3 | $105.77 | $129.92 | |
| Total assets | $1545.18 | $1491.52 | $1574.32 | $1512.91 |
| Current liabilities | ||||
| Accounts payable | $34.09 | $131.21 | $116.7 | $93.37 |
| Deferred revenue | ||||
| Short long term debt | $4.25 | $4.37 | $4.34 | |
| Total current liabilities | $159.01 | $136.97 | $255.17 | $225.41 |
| Long term debt | $596.45 | $616.34 | $622.75 | $619.3 |
| Total noncurrent liabilities | $641.21 | $646.79 | $648.08 | |
| Total debt | $620.58 | $627.12 | $623.64 | |
| Total liabilities | $817.5 | $778.18 | $901.96 | $873.49 |
| Shareholders' equity | ||||
| Retained earnings | $530.82 | $490.39 | $452.44 | $409.27 |
| Other shareholder equity | -$8.82 | -$8.83 | -$8.77 | -$8.48 |
| Total shareholder equity | $713.35 | $672.36 | $639.42 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $144.53 | $156.33 | $126.59 | $94.51 |
| Short term investments | $114.71 | $21.86 | $12.52 | $15.18 |
| Net receivables | $114.94 | $88.97 | $78.8 | $66 |
| Inventory | $105.83 | $103.58 | $92.81 | $96.83 |
| Total current assets | $489.6 | $378.32 | $318.12 | $279.68 |
| Long term investments | $15.21 | $2.41 | $3.98 | |
| Property, plant & equipment | $315.64 | $264.57 | $271.49 | $280.71 |
| Goodwill & intangible assets | $613.29 | $37.3 | $38.87 | $40.62 |
| Total noncurrent assets | $1023.31 | $363.67 | $353.41 | $351.55 |
| Total investments | $129.92 | $24.28 | $16.5 | $15.18 |
| Total assets | $1512.91 | $741.99 | $671.53 | $631.24 |
| Current liabilities | ||||
| Accounts payable | $93.37 | $20.5 | $89.55 | $95.5 |
| Deferred revenue | ||||
| Short long term debt | $4.34 | $6.05 | $5.18 | $15.62 |
| Total current liabilities | $225.41 | $94.86 | $103.81 | $112.2 |
| Long term debt | $619.3 | $72.84 | $99.48 | $51.65 |
| Total noncurrent liabilities | $648.08 | $118.47 | $122.2 | $70.31 |
| Total debt | $623.64 | $102.58 | $104.66 | $67.27 |
| Total liabilities | $873.49 | $213.33 | $226.01 | $182.51 |
| Shareholders' equity | ||||
| Retained earnings | $409.27 | $271.72 | $180.34 | $117.77 |
| Other shareholder equity | -$8.48 | -$8.62 | -$6.76 | -$3.72 |
| Total shareholder equity | $639.42 | $528.66 | $445.52 | $402.31 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $182.39 | $171.84 | $178.1 | |
| Cost of revenue | $87.23 | $81.74 | $81.97 | |
| Gross Profit | $95.17 | $90.1 | $96.14 | |
| Operating activities | ||||
| Research & development | $17.65 | $17.04 | $20.42 | |
| Selling, general & administrative | $22.3 | $25.05 | $21.74 | |
| Total operating expenses | $39.95 | $42.09 | $42.16 | |
| Operating income | $55.22 | $48.01 | $53.98 | |
| Income from continuing operations | ||||
| EBIT | $58.85 | $55.91 | $50.3 | |
| Income tax expense | $12.29 | $4.13 | $4.67 | |
| Interest expense | $8.61 | $8.61 | $9.46 | |
| Net income | ||||
| Net income | $37.95 | $43.18 | $36.17 | |
| Income (for common shares) | $37.95 | $43.18 | $36.17 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $644.39 | $498.99 | $437.77 | $349.85 |
| Cost of revenue | $293.27 | $250.13 | $238.03 | $206.51 |
| Gross Profit | $351.12 | $248.86 | $199.74 | $143.34 |
| Operating activities | ||||
| Research & development | $73.74 | $74.77 | $60.93 | $67.23 |
| Selling, general & administrative | $80.39 | $66.59 | $68.92 | $65.16 |
| Total operating expenses | $154.13 | $141.36 | $129.85 | $132.39 |
| Operating income | $196.99 | $107.5 | $69.89 | $10.95 |
| Income from continuing operations | ||||
| EBIT | $196.54 | $116.71 | $83.63 | $5.32 |
| Income tax expense | $31.83 | $23.48 | $20.63 | $3.54 |
| Interest expense | $27.16 | $1.85 | $0.89 | $0.37 |
| Net income | ||||
| Net income | $137.54 | $91.39 | $62.12 | $1.4 |
| Income (for common shares) | $137.54 | $91.39 | $62.12 | $1.4 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $37.95 | $43.18 | $36.17 | |
| Operating activities | ||||
| Depreciation | $7.95 | $7.8 | $7.61 | |
| Business acquisitions & disposals | -$129 | |||
| Stock-based compensation | $5.78 | $7.36 | $4.62 | |
| Total cash flows from operations | $69.11 | $55.29 | $23.86 | |
| Investing activities | ||||
| Capital expenditures | -$6.04 | -$8.79 | -$9.44 | |
| Investments | $65.78 | $24.99 | -$91.93 | |
| Total cash flows from investing | -$89.25 | -$69.9 | $15.24 | -$103.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$8.5 | |||
| Net borrowings | -$8.03 | $3.73 | -$50.64 | |
| Total cash flows from financing | -$47.11 | -$10.72 | -$13.58 | -$47.08 |
| Effect of exchange rate | -$0.18 | -$0.02 | -$0.1 | -$0.24 |
| Change in cash and equivalents | $47.82 | -$11.53 | $56.85 | -$126.51 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $137.54 | $91.39 | $62.12 | $1.4 |
| Operating activities | ||||
| Depreciation | $28.95 | $27.32 | $25.46 | $20.49 |
| Business acquisitions & disposals | -$506.41 | |||
| Stock-based compensation | $20.24 | $17.86 | $18.69 | $20.5 |
| Total cash flows from operations | $183.5 | $89.18 | $97.99 | $57.27 |
| Investing activities | ||||
| Capital expenditures | -$38.17 | -$23.61 | -$27.46 | -$33.85 |
| Investments | -$105.93 | -$7.79 | $1.4 | -$1.15 |
| Total cash flows from investing | -$649.12 | -$32.78 | -$28.67 | -$36.41 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$58.14 | -$39.91 | -$28.87 | -$24.43 |
| Net borrowings | $501.26 | -$2.19 | $30.36 | -$0.88 |
| Total cash flows from financing | $454.09 | -$26.44 | -$37.02 | -$2.25 |
| Effect of exchange rate | -$0.28 | -$0.22 | -$0.22 | $0.35 |
| Change in cash and equivalents | -$11.8 | $29.75 | $32.08 | $18.96 |
News
Fundamentals
| Market cap | $1.50B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 48.37M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.37 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.43 |
| Quick ratio | 2.61 |